M ost of us are familiar with the signs of acute inflammation. If you’ve ever had a swollen, sprained ankle or a fever from ...
The association between psoriasis severity and CVD may be mediated by systemic inflammation, with a statistically significant ...
EA-230 is under clinical development by Exponential Biotherapies and currently in Phase II for Acute Inflammation.
Oculis’ peptidomimetic small molecule has been shown to help protect the eyes of patients with inflammation of the optic ...
and alterations in the level of serum inflammatory cytokines, acute-phase proteins and total albumin. Such changes are similar to those observed in patients with infectious or inflammatory diseases.
OCS-05 was well tolerated and improved vision and eye health in a Phase 2 trial in 33 people with optic neuritis due to MS or ...
Long-term treatment with guselkumab is associated with sustained improvements in joint/skin symptoms and disease activity among patients with active PsA.
NLRP3 inflammasome activation, pro-inflammatory cytokine production and pyroptosis are key features of inflammation that contribute to liver fibrosis progression, cirrhosis and end-stage liver failure ...
Oculis Holding’s OCS-05 phase 2 ACUITY trial in acute optic neuritis meets primary safety endpoint and key secondary efficacy endpoints: Zug, Switzerland Tuesday, January 7, 202 ...